NICE (UK National Institute for Clinical Excellence) considers ultrasound-guided CVA (central venous access)
This article was originally published in Clinica
The National Institute for Clinical Excellence (NICE) held this week the second appraisal committee meeting on the use of ultrasonic location devices during the insertion of central venous lines. Preliminary guidance recommends that two-dimensional imaging ultrasound be used in the more than 200,000 central venous access (CVA) procedures performed annually by the NHS in England and Wales. In its assessment of CVA technologies, NICE also compares audio-guided Doppler ultrasound location with the traditional, so-called "landmark" method.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.